Keywords: USA, Prescription drug sales, Generics uptake, IMS Health

IMS Health reports bounce-back in US Rx drug sales, which increased 5.1% in 2009 to $300.3 billion, but generics uptake continues

Article | 06 April 2010

Major pharmaceutical market research group IMS Health says that US sales of ethical pharmaceuticals and insulins through retail and non-retail ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in